Cargando…
Evaluating COVID-19 Booster Vaccination Strategies in a Partially Vaccinated Population: A Modeling Study
Background: Several countries are implementing COVID-19 booster vaccination campaigns. The objective of this study was to model the impact of different primary and booster vaccination strategies. Methods: We used a compartmental model fitted to hospital admission data in France to analyze the impact...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952850/ https://www.ncbi.nlm.nih.gov/pubmed/35335111 http://dx.doi.org/10.3390/vaccines10030479 |
_version_ | 1784675717693308928 |
---|---|
author | Massonnaud, Clément R. Roux, Jonathan Colizza, Vittoria Crépey, Pascal |
author_facet | Massonnaud, Clément R. Roux, Jonathan Colizza, Vittoria Crépey, Pascal |
author_sort | Massonnaud, Clément R. |
collection | PubMed |
description | Background: Several countries are implementing COVID-19 booster vaccination campaigns. The objective of this study was to model the impact of different primary and booster vaccination strategies. Methods: We used a compartmental model fitted to hospital admission data in France to analyze the impact of primary and booster vaccination strategies on morbidity and mortality, assuming waning of immunity and various levels of virus transmissibility during winter. Results: Strategies prioritizing primary vaccinations were systematically more effective than strategies prioritizing boosters. Regarding booster strategies targeting different age groups, their effectiveness varied with immunity and virus transmissibility levels. If the waning of immunity affects all adults, people aged 30 to 49 years should be boosted in priority, even for low transmissibility levels. Conclusions: Increasing the primary vaccination coverage should remain a priority. If a plateau has been reached, boosting the immunity of younger adults could be the most effective strategy, especially if SARS-CoV-2 transmissibility is high. |
format | Online Article Text |
id | pubmed-8952850 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89528502022-03-26 Evaluating COVID-19 Booster Vaccination Strategies in a Partially Vaccinated Population: A Modeling Study Massonnaud, Clément R. Roux, Jonathan Colizza, Vittoria Crépey, Pascal Vaccines (Basel) Article Background: Several countries are implementing COVID-19 booster vaccination campaigns. The objective of this study was to model the impact of different primary and booster vaccination strategies. Methods: We used a compartmental model fitted to hospital admission data in France to analyze the impact of primary and booster vaccination strategies on morbidity and mortality, assuming waning of immunity and various levels of virus transmissibility during winter. Results: Strategies prioritizing primary vaccinations were systematically more effective than strategies prioritizing boosters. Regarding booster strategies targeting different age groups, their effectiveness varied with immunity and virus transmissibility levels. If the waning of immunity affects all adults, people aged 30 to 49 years should be boosted in priority, even for low transmissibility levels. Conclusions: Increasing the primary vaccination coverage should remain a priority. If a plateau has been reached, boosting the immunity of younger adults could be the most effective strategy, especially if SARS-CoV-2 transmissibility is high. MDPI 2022-03-19 /pmc/articles/PMC8952850/ /pubmed/35335111 http://dx.doi.org/10.3390/vaccines10030479 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Massonnaud, Clément R. Roux, Jonathan Colizza, Vittoria Crépey, Pascal Evaluating COVID-19 Booster Vaccination Strategies in a Partially Vaccinated Population: A Modeling Study |
title | Evaluating COVID-19 Booster Vaccination Strategies in a Partially Vaccinated Population: A Modeling Study |
title_full | Evaluating COVID-19 Booster Vaccination Strategies in a Partially Vaccinated Population: A Modeling Study |
title_fullStr | Evaluating COVID-19 Booster Vaccination Strategies in a Partially Vaccinated Population: A Modeling Study |
title_full_unstemmed | Evaluating COVID-19 Booster Vaccination Strategies in a Partially Vaccinated Population: A Modeling Study |
title_short | Evaluating COVID-19 Booster Vaccination Strategies in a Partially Vaccinated Population: A Modeling Study |
title_sort | evaluating covid-19 booster vaccination strategies in a partially vaccinated population: a modeling study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952850/ https://www.ncbi.nlm.nih.gov/pubmed/35335111 http://dx.doi.org/10.3390/vaccines10030479 |
work_keys_str_mv | AT massonnaudclementr evaluatingcovid19boostervaccinationstrategiesinapartiallyvaccinatedpopulationamodelingstudy AT rouxjonathan evaluatingcovid19boostervaccinationstrategiesinapartiallyvaccinatedpopulationamodelingstudy AT colizzavittoria evaluatingcovid19boostervaccinationstrategiesinapartiallyvaccinatedpopulationamodelingstudy AT crepeypascal evaluatingcovid19boostervaccinationstrategiesinapartiallyvaccinatedpopulationamodelingstudy |